Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Alfresa Holdings ( (JP:2784) ) just unveiled an announcement.
Alfresa Holdings Corporation announced its transition to a company with an audit and supervisory committee structure, pending approval at the upcoming shareholders’ meeting in June 2025. This transition involves the election of new director candidates and changes to executive personnel, which are expected to enhance the company’s governance and operational oversight.
The most recent analyst rating on (JP:2784) stock is a Hold with a Yen2120.00 price target. To see the full list of analyst forecasts on Alfresa Holdings stock, see the JP:2784 Stock Forecast page.
More about Alfresa Holdings
Alfresa Holdings Corporation operates in the healthcare industry, focusing on the wholesaling of ethical pharmaceuticals and international business.
Average Trading Volume: 511,221
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen414.9B
Learn more about 2784 stock on TipRanks’ Stock Analysis page.